Studies compared multiple routes of administration with and without radiation exposure MINNEAPOLIS–(BUSINESS WIRE)–A recently published paper in Radiation Research, the official journal of the Radiation Research Society, details the results from a series of pharmacokinetics (PK) studies conducted with Humanetics Corporation’s (Humanetics) new radioprotective drug, BIO 300. The studies, which were conducted by researchers at … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “India Ophthalmology Devices Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The Indian ophthalmology devices market is expected to register a CAGR of 7.3% during the forecast period. Ophthalmology-based diseases in India are increasing. According to the 2021 statistics by the HelpMeSee India … [Read more…]
City of Hope Orange County Lennar Foundation Cancer Center is home to a team of cancer-fighting physician-scientists assembled from across the country Key Takeaways: Patients receive fully integrated, multidisciplinary cancer care — from prevention through survivorship — in one convenient location where every physician and staff member is solely focused on treating and curing cancer. … [Read more…]
Accelerating Drug Discovery with Human-Relevant 3D Engineered Muscle Tissue Analysis SEATTLE–(BUSINESS WIRE)–#3DEngineeredMuscleTissues—Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, today announced the commercial launch of the Mantarray™ platform for human-relevant 3D heart and skeletal engineered muscle tissue (EMT) contractility analysis. Curi’s Mantarray platform enables the discovery of new therapeutics by … [Read more…]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–#COVID19—Meissa Vaccines (“Meissa”), a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, today announced that Martin Moore, Ph.D., cofounder and Chief Scientific Officer of Meissa, spoke on a panel entitled, “Innovation in Vaccine Delivery,” at the Summit on the Future of COVID-19 Vaccines hosted by The White House Office for … [Read more…]
NEW YORK–(BUSINESS WIRE)–#cancermoonshot—Medidata, a Dassault Systèmes company, is supporting the White House Cancer Moonshot initiative by working with the National Cancer Institute (NCI) to enroll patients in the Cancer Moonshot Biobank. The Biobank is a project designed to better understand how cancer develops and grows, and why some cancers stop responding to treatment. People with … [Read more…]
Scientists chosen in four categories, including new Representation In SciencE (RISE) Scholar award focused on furthering diversity, equity, inclusion and belonging in the scientific community SAN FRANCISCO–(BUSINESS WIRE)–#Biotech—The Parker Institute for Cancer Immunotherapy (PICI) is helping to forge a future without cancer, by investing in today’s top talent to train and empower the research leaders … [Read more…]
New ticker symbol (Nasdaq: QNCX) to initiate trading on August 1, 2022 SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$CRTX–Cortexyme, Inc. (Nasdaq: CRTX) today announced that the company’s planned corporate name change to Quince Therapeutics is expected take effect on Monday, August 1, 2022. In conjunction with the corporate name change, the company plans to issue a news … [Read more…]
– Publication in Nature Communications Reports that People with Loss of Function Mutations in the INHBE Gene Have Reduced Abdominal Fat, a Favorable Metabolic Profile, and are at Lower Risk of Cardiovascular Disease and Type 2 Diabetes – – Alnylam to Pursue INHBE as a Therapeutic Target for Cardiometabolic Disease – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, … [Read more…]
Increased Provider Access to Real-Time Patient Information Means Greater Efficiency, Enhanced Safety and Lower Costs ARLINGTON, Va.–(BUSINESS WIRE)–#HealthIT–More prescribers and specialty pharmacists nationwide are adopting Surescripts Specialty Medications solutions to transform the manual process used to prescribe specialty medications, saving time and money for patients and providers. In May 2022, the number of prescribers enabled … [Read more…]
